Article - Comment

“Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911)

• Esin Yildiz

Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (Clinical Stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome

• Semih Ayan

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial

• Ali Tekin

Image-guided biopsy-diagnosed renal cell carcinoma: critical appraisal of technique and long-term follow-up

• Özgür Yaycioglu

The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy

• Hayrettin Sahin

Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance

• Kadir Baykal
• Cüneyt Adayener

P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors

• Kadir Türkölmez

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials

• Hakan Gemalmaz

Active surveillance of small renal masses: progression patterns of early stage kidney cancer

• Nurşen Atasoy
• Semih Ayan

Review

Does the Future of Prostate Cancer Treatment Lie with Apoptotic Inducers?

• Dr. Ece Konaç
• Dr. Sinan Sözen

Renal Cell Carcinoma with venous trombosis: Surgical management

• Şevket Tolga Tombul
• Bülent Akdoğan

Approach to the complications of intravesical therapy in bladder cancer

• Turgay Gülecen
• Cüneyd Özkürkçügil

Diagnosis and management of the strictures after prostatectomy

• Murat Akand
• Serdar Göktaş

The influence of age on localized prostate cancer: Surgical result of patients over 70 years

• Erdal Benli
• Ali Ayyıldız

How should be follow-up strategy in stage 1 testicular tumor, are there any novelties?

• Yakup Kordan
• Mehmet Çağatay Çiçek

Management of post-chemotherapy residual masses in testicular tumor and surgical tecnique

• Ferhat Ateş
• Ömer Yılmaz
• Kadir Vehbi Baykal

New chemotherapeutic approaches in testicular tumors

• Arzu Yaren
• Gamze Gököz Doğu
• Serkan Değirmencioğlu

Are there any treatment option for metastatic prostate cancer refractory to docetaksel?

• Yaşar Bedük

Surgical treatment and/or radiotherapy in high risk prostate cancer

• Fatih Bıçaklıoğlu
• Cenk Acar
• Sinan Sözen

New treatment options for the castration resistant prostate cancer targeting the androgen synthesis and androgen receptor

• Yavuz Selim Süral
• Çağ Çal

Current status of pain control in trus-guided prostate biopsy

• İlker Seçkiner
• Ömer Bayrak

Bladder Perforation During TUR of Non Muscle Invasive Bladder Tumours: Early and Late Management

• Deniz Arslan

How shoud PSA repalse (rising PSA) be managed after radical prostatectomy? How should treatment algorithms be shaped?

• İlker Çelen
• Murat Lekili

Management of recurrences after radiation therapy used for curative intent in prostate cancer

• Yılören Tanıdır
• Levent Türkeri

Salvage radical prostatectomy for locally recurrent prostate cancer following primary radiotherapy

• Ali Cansu Bozacı
• Sertaç Yazıcı

Management of infravesical strictures after radical retropubic prostatectomy

• Mustafa Karalar
• İbrahim Keleş
• Mutlu Ateş

AUA/ASTRO 2013 Guidelines for Adjuvant and Salvage Radiation Therapy After Prostatectomy: What are the Yields and the Changes?

• Deniz Yalman

Rising Psa After Radical Prostatectomy: Radiotherapy in High Risk Group: Early? Late?

• Gül Alço
• Sefik İğdem

Update in the management of skeletal related events for metastatic prostate cancer: Denosumab, Alfaradin

• Serdar Çelik
• Uğur Mungan

Most frequently seen side effects of targeted therapy: how to manage?

• Önder Kara
• Bülent Akdoğan

Current situation of the clinical stage I nonseminomatous germ cell testis tumour

• Alim Koşar
• Osman Ergün

Testicular tumors in elderly men

• Deniz Bolat
• Tevfik Haktanır
• Mehmet Ali Ergül

Renal Angiomyolipoma, Review

• Emre Ulukaradag
• Ömür Memik
• Tayyar Alp Özkan

Management of Upper Urinary Tract Tumors: Comparative Oncological Evaluation of Radical Nephroureterectomy and Nephron Sparing Endoscopic Treatments

• Ali Tekin
• Alpaslan Yüksel

The Treatment Modalities in Stage 1 Seminoma; Alterations in Last Five Years

• Baris Kuzgunbay

Hemostatic agents in open partial nephrectomy

• Kemal Ener
• Emrah Okulu
• Önder Kayıgil

Approach to renal cell carcinoma with vena cava and adrenal involvement and interpretation of data of Turkey by 2012

• Mehmet İlker Gökçe

Robotic Prostatectomy: Is it More Advantageous Regarding Quality of Life?

• Olcay Yıldırım
• Kamil Çam

Quality Of Life

How should we manage infertility in testicular cancer patients?

• Hakan Özveri
• Enis Rauf Coşkuner

Management of post radical retropubic prostatectomy incontinence

• Adnan Şimşir
• Gökhan Temeltaş

Does laser prostatectomy provide an advantage regarding quality of life?

• Olcay Yıldırım
• Kamil Çam

Bph

The current status of prostate-specific antigen in the management of Benign Prostatic Hyperplasia

• Ali Tekin

Psycho-Oncology

Psychiatric management strategies in bladder cancer: recommendations to urologists

• M. Ayşin Noyan